cardiovascular system
N |
• blood pressure, heart rate
|
• of mesenteric resistance arteries
• significantly reduced active diameter
• myogenic response activated at significantly lower pressures
• reduced distensibility (increased wall component stiffness)
• significant residual tone in presence of supramaximal concentrations of vasodilator CGRP (calcitonin gene related peptide)
|
growth/size/body
N |
• body weight
|